¿¬±¸µ¿ÇâÁ¤º¸
Á¦¸ñ ±Þ¼º Ãæ¼ö¿°ÀÇ Ç×»ýÁ¦ Ä¡·á¿Í ¼ö¼úÄ¡·á 5³â Àå±âÃßÀû ºñ±³
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

±Þ¼º Ãæ¼ö¿°ÀÇ  Ç×»ýÁ¦ Ä¡·á¿Í ¼ö¼úÄ¡·á 5³â Àå±âÃßÀû ºñ±³

(Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial)

 

[±Ù°Å±â¹Ý ÀÓ»óÁú¹® ´äº¯]  

 

¿¬±¸¸ñÀû

ÇÕº´ÁõÀÌ ¾ø´Â ±Þ¼º Ãæ¼öµ¹±â¿° ȯÀÚ¿¡°Ô Ç×»ýÁ¦Ä¡·á°¡ ¼ö¼úÀÇ ´ë¾ÈÀÌ µÉ ¼ö ÀÖ³ª¿ä?

±Ù°Å±â¹Ý ´äº¯

ÇÕº´ÁõÀÌ ¾ø´Â ±Þ¼º Ãæ¼ö µ¹±â¿° ȯÀÚÀÇ Àå±â ÃßÀû °üÂû°á°ú¸¦ ÅëÇØ ¼ö¼úº¸´Ù´Â Ç×»ýÁ¦ Ä¡·á¸¦ ÅëÇÑ Ãʱâ Ä¡·á°¡ Çö½ÇÀûÀÎ ´ë¾ÈÀÌ µÉ ¼ö ÀÖÀ½À» Á¦¾ÈÇÑ´Ù

¼­ÁöÁ¤º¸

Five-Year Follow-up of Antibiotic Therapy for Uncomplicated Acute Appendicitis in the APPAC Randomized Clinical Trial (2018)  JAMA.;320(12):1259-1265. doi:10.1001/jama.2018.13201

¿¬±¸¸ñÀû

ÇÕº´ÁõÀÌ ¾ø´Â ±Þ¼ºÃæ¼öµ¹±â¿°(Uncomplicated Acute Appendicitis)Ä¡·á¸¦ À§ÇØ Ç×»ýÁ¦ »ç¿ëÀÌ Ãæ¼ö¿° Àç¹ß·ü¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» 5³â Àå±âÃßÀûÀ» ÅëÇØ È®ÀÎ

¿¬±¸¼³°è

Randomized clinical trial: Five-year observational follow-up

¿¬±¸´ë»ó

ÇÕº´ÁõÀÌ ¾ø´Â Ãæ¼öµ¹±â¿° ȯÀÚ (18¼¼ ~ 60¼¼) : N=530

½ÃÇ豺 ÁßÀç

Ç×»ýÁ¦Ä¡·á (Antibiotic therapy) : n=257

Á¤¸ÆÁÖ»ç ertapenem 3ÀÏÅõ¿©

7ÀÏ µ¿¾ÈÀÇ  ±¸°­º¹¿ë levofloxacin and metronidazole.)

´ëÁ¶±º ÁßÀç

Ãæ¼öÀýÁ¦¼ú (Open appendectomy) : n=273

Æò°¡ÁöÇ¥

Ç×»ýÁ¦Ä¡·á ÈÄ Ãæ¼öµ¹±â¿° Àç¹ß·ü ( appendicitis recurrence)

ÇÕº´Áõ (complications),

º´¿øÀÔ¿øÀϼö((ength of hospital stay)

º´°¡ (sick leave)

ÁÖ¿ä°á°ú

ÇÕº´ÁõÀÌ ¾ø´Â ±Þ¼º Ãæ¼ö µ¹±â¿° ȯÀÚ¿¡¼­ Ãʱâ Ç×»ýÁ¦ Ä¡·á¸¦ ¹ÞÀº 257 ¸íÀÇ È¯ÀÚ¸¦ ´ë»óÀ¸·Î 5 ³â°£ ÃßÀû °üÂû ÇÑ °á°ú, 1 ³â, 2 ³â, 3 ³â, 4 ³â ¹× 5 ³âÀÇ Ãæ¼ö¿°ÀÇ Àç¹ß ´©Àû ¹ß»ý·üÀº 1 ³â¿¡ 27.3 %, 2 ³â¿¡ 34.0 % , 3³â¿¡ 35.2 %, 4³â ¶§ 37.1 %, 5³â ¶§ 39.1 %·Î º¸°íµÇ¾ú´Ù.

5³â Àå±â ÃßÀûºñ±³ °á°ú, Ãæ¼öÀýÁ¦¼úÀ» ¹ÞÀº ȯÀÚ±º¿¡¼­ ÇÕº´Áõ ¹ß»ý·ü(¼ö¼úºÎÀ§ °¨¿°, Àý°³°¨¿°, Å»Àå, º¹Åë µî)ÀÌ ³ô°Ô º¸°íµÇ¾úÀ¸¸ç, ±×·ì°£ÀÇ ÀÔ¿øÀϼö´Â Â÷ÀÌ°¡ ¾ø¾ú°í, º´°¡Àϼö´Â Ãæ¼öµ¹±âÀýÁ¦±º¿¡¼­ 11ÀÏÀÌ»ó À¯ÀÇÇÏ°Ô ³ô°Ô³ªÅ¸³µ´Ù.

±Ù°Å¼öÁØ

High

ÀÛ¼ºÀÚ

ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedRIC)

Copyright © 2015. Medical Research Information Center (MedRIC) Editors


 


2018-11-16 ¿ÀÈÄ 1:25:04, Á¶È¸¼ö : 1561